Skip to main content

Quadrant Capital Group LLC

SEC CIK
0001650717
Latest filing
Aug 14, 2026

MDGL holding history

Madrigal Pharmaceuticals, Inc. in every 13F filed by Quadrant Capital Group LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

MDGL overviewAll 13F holders of MDGLFull Q2 2026 holdings

Shares (Q2 2026)
2,605
Value
$1.40M
% of portfolio
<0.1%
Quarters held
21
Since Q1 2021
Holdings of MDGL by Quadrant Capital Group LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20262,605$1.40M<0.1%00.0%UnchangedHolders
Q1 20262,605$1.36M<0.1%00.0%UnchangedHolders
Q4 20252,605$1.52M<0.1%00.0%UnchangedHolders
Q3 20252,605$1.19M<0.1%00.0%UnchangedHolders
Q2 20252,605$788.4K<0.1%−16−0.6%ReducedHolders
Q1 20252,621$868.2K<0.1%+2,599+11,813.6%AddedHolders
Q4 202422$6.79K<0.1%00.0%UnchangedHolders
Q3 202422$4.67K<0.1%00.0%UnchangedHolders
Q2 202422$6.16K<0.1%−20−47.6%ReducedHolders
Q1 202442$11.2K<0.1%+20+90.9%AddedHolders
Q4 202322$5.09K<0.1%+9+69.2%AddedHolders
Q3 202313$1.90K<0.1%−1−7.1%ReducedHolders
Q2 202314$3.23K<0.1%+1+7.7%AddedHolders
Q1 202313$3.15K<0.1%−30−69.8%ReducedHolders
Q4 202243$12.5K<0.1%+43NewHolders
Q3 20220$00.0%−3−100.0%Sold outHolders
Q2 20223$00.0%00.0%UnchangedHolders
Q1 20223$00.0%+2+200.0%AddedHolders
Q4 20211$00.0%−15−93.8%ReducedHolders
Q3 202116$1.00K<0.1%+14+700.0%AddedHolders
Q2 20212$00.0%−1−33.3%ReducedHolders
Q1 20213$00.0%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.